StockData
Johnson & Johnson logo

Johnson & Johnson (JNJ) operating KPIs

JNJNYSEPharmaceutical PreparationsFiscal year ends January 3
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Oct 21, 2026Score 12/3043% above fair value
$273.20−2.00 (-0.73%)

Close on Oct 30, 2026Market cap $658.38BP/E 31.7Yield 1.88%

Johnson & Johnson full-Year Guidance — Operational sales midpoint ($B)

Form 8-K EX-99.1 Full-Year Guidance Table

Latest, Q3 2026
100.70
Period ended Sep 30, 2026
Change on a year earlier
+8.0%
93.20 in Q3 2025
History
17 quarters
Since Q3 2022
Sources
17
Documents cited below

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedFull-Year Guidance — Operational sales midpoint ($B)Year on yearSource
Q3 2026Sep 30, 2026100.70+8.0%Form 8-K (a2026q3exhibit991.htm, filed 2026-10-13) ↗
Q2 2026Jun 28, 2026100.60+8.3%Form 8-K (a2026q2exhibit991.htm, filed 2026-07-15) ↗
Q1 2026Mar 29, 2026100.20+8.9%Form 8-K (a2026q1exhibit991.htm, filed 2026-04-14) ↗
Q4 2025Dec 28, 2025100.00+9.5%Form 8-K (a2025q4exhibit991.htm, filed 2026-01-21) ↗
Q3 2025Sep 28, 202593.20+4.0%Form 8-K (a2025q3exhibit991.htm, filed 2025-10-14) ↗
Q2 2025Jun 29, 202592.90+3.9%Form 8-K (a2025q2exhibit991.htm, filed 2025-07-16) ↗
Q1 2025Mar 30, 202592.00+4.5%Form 8-K (a2025q1exhibit991.htm, filed 2025-04-15) ↗
Q4 2024Dec 29, 202491.30+3.0%Form 8-K (a2024q4exhibit991.htm, filed 2025-01-22) ↗
Q3 2024Sep 29, 202489.60+5.9%Form 8-K (a2024q3exhibit991.htm, filed 2024-10-15) ↗
Q2 2024Jun 30, 202489.40-10.4%Form 8-K (a2024q2exhibit991.htm, filed 2024-07-17) ↗
Q1 2024Mar 31, 202488.00-10.6%Form 8-K (a2024q1exhibit991.htm, filed 2024-04-16) ↗
Q4 2023Dec 31, 202388.60-9.0%Form 8-K (a2023q4exhibit991.htm, filed 2024-01-23) ↗
Q3 2023Oct 1, 202384.60-13.5%Form 8-K (a2023q3exhibit991.htm, filed 2023-10-17) ↗
Q2 2023Jul 2, 202399.80–Form 8-K (a2023q2exhibit991.htm, filed 2023-07-20) ↗
Q1 2023Apr 2, 202398.40–Form 8-K (a2023q1exhibit991.htm, filed 2023-04-18) ↗
Q4 2022Jan 1, 202397.40–Form 8-K (a2022q4exhibit991.htm, filed 2023-01-24) ↗

Cite this data

StockData. (2026). Johnson & Johnson Full-Year Guidance — Operational sales midpoint ($B), quarterly Q3 2022–Q3 2026 [Data set]. Compiled from Johnson & Johnson SEC filings and investor materials. https://stockdatahq.com/stocks/jnj/kpis/guid_ops_sales_mid_b

See every metric in the Johnson & Johnson KPI table. Data updated Oct 25, 2026.